Connor, Clark & Lunn Investment Management (CC&L)’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.06M | Sell |
|
|||||
|
2025
Q1 | $2.88M | Buy |
|
|||||
|
2024
Q4 | $430K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $13.7M | Sell |
|
|||||
|
2023
Q1 | $10M | Buy |
|
|||||
|
2022
Q4 | $3.98M | Buy |
|
|||||
|
2022
Q3 | $363K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $445K | Sell |
|
|||||
|
2021
Q3 | $2.55M | Buy |
|
|||||
|
2021
Q2 | $1.16M | Buy |
|